These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17592099)

  • 1. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
    Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD
    Arch Intern Med; 2007 Jun; 167(12):1262-70. PubMed ID: 17592099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
    Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
    Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease.
    Veringa SJ; Nanayakkara PW; van Ittersum FJ; Vegting IL; van Guldener C; Smulders YM; ter Wee PM; Stehouwer CD
    Clin Nephrol; 2012 Oct; 78(4):263-72. PubMed ID: 22981031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial.
    Nafar M; Khatami F; Kardavani B; Farjad R; Pour-Reza-Gholi F; Firouzan A; Kalantar A; Farhangi S; Einollahi B
    Exp Clin Transplant; 2009 Mar; 7(1):33-9. PubMed ID: 19364310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
    Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
    Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
    Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure?
    Bennett-Richards K; Kattenhorn M; Donald A; Oakley G; Varghese Z; Rees L; Deanfield JE
    Circulation; 2002 Apr; 105(15):1810-5. PubMed ID: 11956124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease.
    Tonelli M; Moyé L; Sacks FM; Cole T; Curhan GC;
    J Am Soc Nephrol; 2003 Jun; 14(6):1605-13. PubMed ID: 12761262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease.
    Title LM; Cummings PM; Giddens K; Genest JJ; Nassar BA
    J Am Coll Cardiol; 2000 Sep; 36(3):758-65. PubMed ID: 10987596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Laitinen T; Marniemi J; Helenius H; Rönnemaa T; Raitakari OT
    Circulation; 2004 Nov; 110(18):2918-23. PubMed ID: 15505080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients.
    Tungkasereerak P; Ong-ajyooth L; Chaiyasoot W; Ong-ajyooth S; Leowattana W; Vasuvattakul S; Vareesangthip K; Shayakul C; Chanchairujira T; Sritippayawan S
    J Med Assoc Thai; 2006 Aug; 89(8):1187-93. PubMed ID: 17048428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients.
    Marcucci R; Zanazzi M; Bertoni E; Rosati A; Fedi S; Lenti M; Prisco D; Castellani S; Abbate R; Salvadori M
    Transplant Proc; 2005; 37(6):2491-2. PubMed ID: 16182720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial.
    Woodside JV; Yarnell JW; McMaster D; Young IS; Harmon DL; McCrum EE; Patterson CC; Gey KF; Whitehead AS; Evans A
    Am J Clin Nutr; 1998 May; 67(5):858-66. PubMed ID: 9583842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
    Asselbergs FW; van Roon AM; Hillege HL; de Jong PE; Gans RO; Smit AJ; van Gilst WH;
    Stroke; 2005 Mar; 36(3):649-53. PubMed ID: 15692120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine or renal impairment: which is the real cardiovascular risk factor?
    Potter K; Hankey GJ; Green DJ; Eikelboom JW; Arnolda LF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1158-64. PubMed ID: 18356552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
    Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
    JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis.
    Potter K; Hankey GJ; Green DJ; Eikelboom J; Jamrozik K; Arnolda LF
    BMC Cardiovasc Disord; 2008 Sep; 8():24. PubMed ID: 18803866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of folic acid supplementation on carotid intima-media thickness in patients with cardiovascular risk: a randomized, placebo-controlled trial.
    Ntaios G; Savopoulos C; Karamitsos D; Economou I; Destanis E; Chryssogonidis I; Pidonia I; Zebekakis P; Polatides C; Sion M; Grekas D; Hatzitolios A
    Int J Cardiol; 2010 Aug; 143(1):16-9. PubMed ID: 19201496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.